Open comment period closing soon!
🔹Draft Recommendations: Molecular MRD Monitoring in AML 🔹
Read the recommendations and submit your comments here: https://t.co/2o7eM0e7e9
Deadline: Nov. 24, 2026, at 11:59 p.m. Eastern
so apparently this robot can now destroy a tumor inside your body using nothing but sound
no cuts, no needles and no radiation, and most patients even go home the same day!
it's called histotripsy, and the company behind the machine (HistoSonics) is backed by Jeff Bezos and valued at $3.75 billion
more than 2,000 people at 50+ US hospitals have already been treated with it
> you lie under a robot arm holding an ultrasound head over your belly
> the doctor marks the tumor on a live ultrasound image
> the robot fires short, intense pulses of sound focused on that one spot
> each pulse makes a cloud of tiny bubbles appear inside the tumor and burst in millionths of a second
> the bursting rips the tumor cells apart until they turn to liquid
> then your immune system clears the mess away over the next few weeks
in the main trial, 90% of the treated liver tumors were still under control a year later
and they're already testing it on kidney tumors and prostates
we're popping cancer with sound now lol
A first of its kind vaccine for acute myeloid leukemia, a deadly blood cancer, succeeded in a Phase 3 clinical trial, drugmaker Sellas Life Sciences and Memorial Sloan Kettering Cancer Center announced. https://t.co/RjBzKDNHif
The biggest advantage of a top lab may not be money.
It may be that it saves you years.
In a weak lab, a PhD student can spend six months chasing a question that everyone in the field already knows is a dead end.
You can build the wrong experiment, optimize the wrong metric, write a paper nobody important cares about, and only discover that after the rejection arrives.
In a great lab, that mistake often dies in a 20-minute meeting.
A senior postdoc has seen the failure before. A collaborator knows the dataset is bad.
Your PI knows which result is merely “interesting” and which one could become a serious paper.
Someone in the room has reviewed for the conference, knows the standard, and can tell you immediately where the story breaks.
That kind of knowledge rarely appears in textbooks.
It gets transmitted over group meetings, draft comments, conference dinners, Slack messages and watching experienced people make decisions in real time.
This is why “research taste” is so unevenly distributed.
Some PhD students have to invent it from scratch.
Others absorb it every week from people who already know what an important problem looks like.
And once you understand that, the advantage of Stanford, MIT, Broad or a top industrial lab starts to look very different.
They are not only giving you better resources.
They are compressing the learning curve.
A mediocre environment can make a talented student waste three years proving things that never mattered.
A great environment can make the same student look “gifted” simply because fewer years were wasted on the wrong problems.
The richest labs do not just buy better experiments.
They buy fewer wasted years.
Genomic Tessellations....imagine a genomic mosaic, not laid out flat like a tiled floor, but folded into a 3D arrangement.... stretches of DNA fitting into a molecular puzzle, forming patterns within patterns...its like nature's own game of Tetris...